相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Orthopoxvirus K3 orthologs show virus- and host-specific inhibition of the antiviral protein kinase PKR
Chorong Park et al.
PLOS PATHOGENS (2021)
Repair of a previously uncharacterized second host-range gene contributes to full replication of modified vaccinia virus Ankara (MVA) in human cells
Chen Peng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Deletion of Vaccinia Virus A40R Gene Improves the Immunogenicity of the HIV-1 Vaccine Candidate MVA-B
Patricia Perez et al.
VACCINES (2020)
Tauopathy Analysis in P301S Mouse Model of Alzheimer Disease Immunized with DNA and MVA Poxvirus-Based Vaccines Expressing Human Full-Length 4R2N or 3RC Tau Proteins
Juan Garcia-Arriaza et al.
VACCINES (2020)
THE HIDDEN HISTORY OF ANCIENT PLAGUES
Laura Spinney
NATURE (2020)
Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platform
Flavia Chiuppesi et al.
NATURE COMMUNICATIONS (2020)
Diverse variola virus (smallpox) strains were widespread in northern Europe in the Viking Age
Barbara Muehlemann et al.
SCIENCE (2020)
Histone deacetylase 4 promotes type I interferon signaling, restricts DNA viruses, and is degraded via vaccinia virus protein C6
Yongxu Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
SPI-1 is a missing host-range factor required for replication of the attenuated modified vaccinia Ankara (MVA) vaccine vector in human cells
Ruikang Liu et al.
PLOS PATHOGENS (2019)
HIV therapeutic vaccine enhances non-exhausted CD4+ T cells in a randomised phase 2 trial
Vincent Vieillard et al.
NPJ VACCINES (2019)
Modified Vaccinia Virus Ankara Can Induce Optimal CD8+T Cell Responses to Directly Primed Antigens Depending on Vaccine Design
Yik Chun Wong et al.
JOURNAL OF VIROLOGY (2019)
Generation of recombinant MVA-norovirus: a comparison study of bacterial artificial chromosome- and marker-based systems
Franziska Kugler et al.
VIROLOGY JOURNAL (2019)
Deletion of Apoptosis Inhibitor F1L in Vaccinia Virus Increases Safety and Oncolysis for Cancer Therapy
Adrian Pelin et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
Novel Modified Vaccinia Virus Ankara Vector Expressing Antiapoptotic Gene B13R Delays Apoptosis and Enhances Humoral Responses
Lynette S. Chea et al.
JOURNAL OF VIROLOGY (2019)
ORF6 and ORF61 Expressing MVA Vaccines Impair Early but Not Late Latency in Murine Gammaherpesvirus MHV-68 Infection
Baila Samreen et al.
FRONTIERS IN IMMUNOLOGY (2019)
First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector
Lindsey R. Baden et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Virulent Poxviruses Inhibit DNA Sensing by Preventing STING Activation
Iliana Georgana et al.
JOURNAL OF VIROLOGY (2018)
Modulating Vaccinia Virus Immunomodulators to Improve Immunological Memory
Jonas D. Albarnaz et al.
VIRUSES-BASEL (2018)
Unique Action of Interleukin-18 on T Cells and Other immune Cells
Kenji Nakanishi
FRONTIERS IN IMMUNOLOGY (2018)
Removal of the C6 Vaccinia Virus Interferon- Inhibitor in the Hepatitis C Vaccine Candidate MVA-HCV Elicited in Mice High Immunogenicity in Spite of Reduced Host Gene Expression
Maria Q. Marin et al.
VIRUSES-BASEL (2018)
Vaccinia virus egress mediated by virus protein A36 is reliant on the F12 protein
David C. J. Carpentier et al.
JOURNAL OF GENERAL VIROLOGY (2017)
Equination (inoculation of horsepox): An early alternative to vaccination (inoculation of cowpox) and the potential role of horsepox virus in the origin of the smallpox vaccine
Jose Esparza et al.
VACCINE (2017)
Oral vaccination of wildlife using a vaccinia-rabies-glycoprotein recombinant virus vaccine (RABORAL V-RG®): a global review
Joanne Maki et al.
VETERINARY RESEARCH (2017)
Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus Infections
Iuliia Gilchuk et al.
CELL (2016)
17th Century Variola Virus Reveals the Recent History of Smallpox
Ana T. Duggan et al.
CURRENT BIOLOGY (2016)
Deletion of A44L, A46R and C12L Vaccinia Virus Genes from the MVA Genome Improved the Vector Immunogenicity by Modifying the Innate Immune Response Generating Enhanced and Optimized Specific T-Cell Responses
Maria Pia Holgado et al.
VIRUSES-BASEL (2016)
Vaccinia Virus Protein C6 Inhibits Type I IFN Signalling in the Nucleus and Binds to the Transactivation Domain of STAT2
Jennifer H. Stuart et al.
PLOS PATHOGENS (2016)
RAB1A promotes Vaccinia virus replication by facilitating the production of intracellular enveloped virions
Tali Pechenick Jowers et al.
VIROLOGY (2015)
The Evolution of Poxvirus Vaccines
Lucas Sanchez-Sampedro et al.
VIRUSES-BASEL (2015)
Identification of Restriction Factors by Human Genome-Wide RNA Interference Screening of Viral Host Range Mutants Exemplified by Discovery of SAMD9 and WDR6 as Inhibitors of the Vaccinia Virus K1L-C7L- Mutant
Gilad Sivan et al.
MBIO (2015)
Analysis of the anti-apoptotic activity of four vaccinia virus proteins demonstrates that B13 is the most potent inhibitor in isolation and during viral infection
David L. Veyer et al.
JOURNAL OF GENERAL VIROLOGY (2014)
Recombinant Modified Vaccinia Virus Ankara Generating Excess Early Double-Stranded RNA Transiently Activates Protein Kinase R and Triggers Enhanced Innate Immune Responses
Michael Wolferstaetter et al.
JOURNAL OF VIROLOGY (2014)
Matrix and Backstage: Cellular Substrates for Viral Vaccines
Ingo Jordan et al.
VIRUSES-BASEL (2014)
Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases
Arwen F. Altenburg et al.
VIRUSES-BASEL (2014)
Enhancing poxvirus vectors vaccine immunogenicity
Juan Garcia-Arriaza et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Regulation of 3β-Hydroxysteroid Dehydrogenase/Δ5-Δ4 Isomerase: A Review
Martin Kroyer Rasmussen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Deletion of the Vaccinia Virus Gene A46R, Encoding for an Inhibitor of TLR Signalling, Is an Effective Approach to Enhance the Immunogenicity in Mice of the HIV/AIDS Vaccine Candidate NYVAC-C
Beatriz Perdiguero et al.
PLOS ONE (2013)
Poxvirus DNA Replication
Bernard Moss
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Recombinant vaccines and the development of new vaccine strategies
I. P. Nascimento et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2012)
The Vaccinia Virus-Encoded Bcl-2 Homologues Do Not Act as Direct Bax Inhibitors
Antonio Postigo et al.
JOURNAL OF VIROLOGY (2012)
Improving the MVA Vaccine Potential by Deleting the Viral Gene Coding for the IL-18 Binding Protein
Juliana Falivene et al.
PLOS ONE (2012)
Smallpox vaccines: targets of protective immunity
Bernard Moss
IMMUNOLOGICAL REVIEWS (2011)
Genomic Analysis of the Vaccinia Virus Strain Variants Found in Dryvax Vaccine
Li Qin et al.
JOURNAL OF VIROLOGY (2011)
Deletion of the A35 gene from Modified Vaccinia Virus Ankara increases immunogenicity and isotype switching
Kristina E. Rehm et al.
VACCINE (2011)
Vaccinia Virus Protein C6 Is a Virulence Factor that Binds TBK-1 Adaptor Proteins and Inhibits Activation of IRF3 and IRF7
Leonie Unterholzner et al.
PLOS PATHOGENS (2011)
Concomitant type I IFN receptor-triggering of T cells and of DC is required to promote maximal modified vaccinia virus Ankara-induced T-cell expansion
Theresa Frenz et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Third-generation smallpox vaccines: challenges in the absence of clinical smallpox
Clement A. Meseda et al.
FUTURE MICROBIOLOGY (2010)
Rapid generation of markerless recombinant MVA vaccines by en passant recombineering of a self-excising bacterial artificial chromosome
Matthew G. Cottingham et al.
JOURNAL OF VIROLOGICAL METHODS (2010)
Vaccinia virus A35R inhibits MHC class II antigen presentation
Kristina E. Rehm et al.
VIROLOGY (2010)
Vaccinia virus vaccines: Past, present and future
Bertram L. Jacobs et al.
ANTIVIRAL RESEARCH (2009)
Differentiation of Variola major and Variola minor variants by MGB-Eclipse probe melt curves and genotyping analysis
Bonnie M. Loveless et al.
MOLECULAR AND CELLULAR PROBES (2009)
New generation smallpox vaccines: a review of preclinical and clinical data
Andrew W. Artenstein
REVIEWS IN MEDICAL VIROLOGY (2008)
Identification from diverse mammalian poxviruses of host-range regulatory genes functioning equivalently to vaccinia virus C7L
Xiangzhi Meng et al.
VIROLOGY (2008)
Vaccinia virus E3 protein prevents the antiviral action of ISG15
Susana Guerra et al.
PLOS PATHOGENS (2008)
Expression of the E3L gene of vaccinia virus in transgenic mice decreases host resistance to vaccinia virus and Leishmania major infections
Elena Domingo-Gil et al.
JOURNAL OF VIROLOGY (2008)
Safety immunogenicity and protective efficacy in mice of a new cell-cultured Lister smallpox vaccine candidate
Audrey Ferrier-Rembert et al.
VACCINE (2007)
On the origin of smallpox: Correlating variola phylogenics with historical smallpox records
Yu Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Colocalization of transcription and translation within cytoplasmic poxvirus factories coordinates viral expression and subjugates host functions
George C. Katsafanas et al.
CELL HOST & MICROBE (2007)
Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus
Christopher T. Jones et al.
JOURNAL OF VIROLOGY (2007)
Ethical reflections on Edward Jenner's experimental treatment
Hugh Davies
JOURNAL OF MEDICAL ETHICS (2007)
LC16m8, a highly attenuated vaccinia virus vaccine lacking expression of the membrane protein B5R, protects monkeys from monkeypox
Masayuki Saijo et al.
JOURNAL OF VIROLOGY (2006)
Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challenge
C Empig et al.
VACCINE (2006)
Deletion of gene A41L enhances vaccinia virus immunogenicity and vaccine efficacy
RH Clark et al.
JOURNAL OF GENERAL VIROLOGY (2006)
Characterization of the vaccinia virus A35R protein and its role in virulence
RL Roper
JOURNAL OF VIROLOGY (2006)
Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus
KJ Stittelaar et al.
JOURNAL OF VIROLOGY (2005)
The history of vaccines and immunization: Familiar patterns, new challenges
AM Stern et al.
HEALTH AFFAIRS (2005)
Role of viral factor E3L in modified vaccinia virus Ankara infection of human HeLa cells: Regulation of the virus life cycle and identification of differentially expressed host genes
H Ludwig et al.
JOURNAL OF VIROLOGY (2005)
Engineering of a vaccinia virus bacterial artificial chromosome in Escherichia coli by bacteriophage λ-based recombination
A Domi et al.
NATURE METHODS (2005)
Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin
E Bell et al.
VIROLOGY (2004)
Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential?
I Drexler et al.
CURRENT OPINION IN BIOTECHNOLOGY (2004)
Vaccinia virus interleukin-18-binding protein promotes virulence by reducing gamma interferon production and natural killer and T-Cell activity
PC Reading et al.
JOURNAL OF VIROLOGY (2003)
Replication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L
S Hornemann et al.
JOURNAL OF VIROLOGY (2003)
Smallpox vaccination: A review, part I. Background, vaccination technique, normal vaccination and revaccination, and expected normal reactions
VA Fulginiti et al.
CLINICAL INFECTIOUS DISEASES (2003)
Steroid hormone synthesis by vaccinia virus suppresses the inflammatory response to infection
PC Reading et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
The formation and function of extracellular enveloped vaccinia virus
GL Smith et al.
JOURNAL OF GENERAL VIROLOGY (2002)
Structural analysis of vaccinia virus dls strain: Application as a new replication-deficient viral vector
K Ishii et al.
VIROLOGY (2002)
Developing new smallpox vaccines
SR Rosenthal et al.
EMERGING INFECTIOUS DISEASES (2001)
Vaccinia virus DNA replication occurs in endoplasmic reticulum-enclosed cytoplasmic mini-nuclei
N Tolonen et al.
MOLECULAR BIOLOGY OF THE CELL (2001)
分享论文
